Publications by authors named "M Platania"

ICONIC is a multicenter, open-label, nonrandomized phase II clinical trial aiming to assess the feasibility and clinical activity of the addition of carbon ion radiotherapy to immune checkpoint inhibitors in cancer patients who have obtained disease stability with pembrolizumab administered as per standard-of-care. The primary end point is objective response rate, and the secondary end points are safety, survival and disease control rate. Translational research is an exploratory aim.

View Article and Find Full Text PDF

Background: Systemic immunosuppression characterizing cancer patients represents a concern regarding the efficacy of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, and real-world evidence is needed to define the efficacy and the dynamics of humoral immune response to mRNA-based anti-SARS-CoV-2 vaccines.

Methods: We conducted an observational study that included patients with solid tumors who were candidates for mRNA anti-SARS-CoV-2 vaccination at the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. The primary objective was to monitor the immunologic response to the mRNA anti-SARS-CoV-2 vaccination in terms of anti-spike antibody levels.

View Article and Find Full Text PDF

Volcanic sites can be considered strategic areas for conservation and protection policies, but such policies may involve considerable costs However, not only are volcanic sites often integral to the tourism industry and, hence, of potential significant benefit to local economies in general; entrance fee income from tourists can also contribute to management and conservation costs in particular. Nevertheless, seasonal variations in tourism demand, resulting in over-and under-tourism situations, may impact on both the level of income generated as well as on the sustainability of sites Therefore, based on a case study of Mt Etna in Italy, this study considers establishing appropriate entry fee levels for volcano areas. First, a logit model is applied to the relevant socio-demographic and site-specific variables.

View Article and Find Full Text PDF

Background: Cancer-related fatigue (CRF) is common in patients with advanced solid tumors and several risk factors are described. The possible role of depression is reported by clinicians despite the association with CRF being unclear.

Material And Methods: In this monocentric, cross-sectional, prospective study we recruited patients with advanced solid tumors who were hospitalized at Fondazione IRCCS Istituto Nazionale dei Tumori of Milan.

View Article and Find Full Text PDF
Article Synopsis
  • - Paraneoplastic syndromes, affecting about 0.1% of cancer patients, are more common in certain tumors like Small Cell Lung Cancer (SCLC) and Thymoma, as they trigger autoimmune responses against nervous system factors produced by the tumors.
  • - The article discusses the relationship between immunotherapy and paraneoplastic neurological syndromes (PNS), highlighting that the use of immunotherapy in SCLC may lead to an increase in autoimmune neurological symptoms.
  • - The authors share their experience with three patients at the Istituto Nazionale Tumori in Milan, noting that typical cancer treatments have little effect on neurological deficits caused by PNS, indicating a need for more research to improve patient care.
View Article and Find Full Text PDF